Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,414.15", "chg": 77, "chgp": "1.44%", "dir": 1, "prev_price": "5,337.15", "mcapval": "63,679.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "Sep 23, 03:30 PM", "curr_time": "06:53 AM", "last_traded_at": "Sep 23, 03:30 PM IST", "bse_nse_vol": "1.91 lacs", "exc_status": "Active", "traded_date": "Sep 23, 2026", "traded_date_str": "2026 09 23", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Alkem Laboratories Ltd Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-technical-momentum-shifts-amid-bearish-signals-4200405", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_technicaldot_4200405.png", "date": "2026-09-22 08:06:46", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish territory. Despite a recent downgrade in price performance, the stock’s medium-term fundamentals and long-term returns continue to present a mixed but cautiously watchful outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Trends", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financial-trends-4199241", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_mojoScore_4199241.png", "date": "2026-09-21 08:14:00", "description": "Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality. This shift comes amid a backdrop of flat quarterly financial performance but positive long-term returns and a more favourable technical outlook." }, { "title": "Alkem Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4199134", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_technicaldot_4199134.png", "date": "2026-09-21 08:03:32", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, as reflected in recent market data and technical indicators. Despite a 3.03% gain on 21 Sep 2026, the stock’s mixed signals from MACD, RSI, and moving averages suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Alkem Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4197202", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_mojoScore_4197202.png", "date": "2026-09-18 10:11:10", "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Alkem Laboratories Declines 1.97%: Bearish Technicals and Flat Earnings Weigh", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-declines-197-bearish-technicals-and-flat-earnings-weigh-4191310", "imagepath": "", "date": "2026-09-12 13:00:49", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>7 Sep:</strong> Downgrade to Sell rating amid technical weakness and flat financials</p>\n <p><strong>7 Sep:</strong> Bearish technical shift confirmed with mixed momentum signals</p>\n <p><strong>11 Sep:</strong> Stock hits 52-week low at Rs.5,052.05 amid market downturn</p>\n <p><strong>11 Sep:</strong> Week closes at Rs.5,089.50, down 1.97%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,192.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..." }, { "title": "Markets Rally, But Alkem Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-stock-hits-52-week-low-amidst-market-downturn-4190145", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_priceRelatedfactors_4190145.png", "date": "2026-09-11 09:51:02", "description": "" }, { "title": "Alkem Laboratories Downgraded to Sell Amid Technical Weakness and Flat Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-technical-weakness-and-flat-financials-4184975", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_mojoScore_4184975.png", "date": "2026-09-07 08:16:51", "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 September 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and waning promoter confidence, despite the company’s strong management efficiency and net-debt-free status." }, { "title": "Alkem Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-4184745", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlkemLaboratori_technicaldot_4184745.png", "date": "2026-09-07 08:03:50", "description": "Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day gain of 0.14%, the pharmaceutical giant’s technical parameters reveal a complex picture of weakening momentum and cautious investor sentiment as it navigates a challenging market environment." }, { "title": "Alkem Laboratories Ltd Declines 2.96%: 4 Key Technical Shifts Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-declines-296-4-key-technical-shifts-shape-weekly-trend-4183525", "imagepath": "", "date": "2026-09-05 14:01:16", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> Mildly bullish technical momentum shift</p>\n <p><strong>2 Sep:</strong> Technical momentum shifts to sideways trend</p>\n <p><strong>3 Sep:</strong> Death Cross formation signals potential bearish trend</p>\n <p><strong>4 Sep:</strong> Momentum shifts to mildly bearish stance</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,350.15</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.5,192.00</div><div class=\"stat-c..." } ], "total": 667, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "22-Sep-2026", "details": "Please find attached herewith intimation for closure of trading window.", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations", "datetime": "21-Sep-2026", "details": "Please find attached herewith intimation for issue of corporate guarantee by the Company.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "16-Sep-2026", "details": "Alkem Laboratories Limited launches NeuCeno (cenobamate) for the treatment of partial - onset seizures in adult patients.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Aug 26", "dt": "2026-08-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

7 Sep: Downgrade to Sell rating amid technical weakness and flat financials

7 Sep: Bearish technical shift confirmed with mixed momentum signals

11 Sep: Stock hits 52-week low at Rs.5,052.05 amid market downturn

11 Sep: Week closes at Rs.5,089.50, down 1.97%

Week Open

Rs.5,192.00

Week Close

Read full news article

Markets Rally, But Alkem Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-09-11 09:51:02

Read full news article

Alkem Laboratories Downgraded to Sell Amid Technical Weakness and Flat Financials

2026-09-07 08:16:51

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 4 September 2026. This shift reflects deteriorating technical indicators, flat recent financial performance, and waning promoter confidence, despite the company’s strong management efficiency and net-debt-free status.

Read full news article

Alkem Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals

2026-09-07 08:03:50

Alkem Laboratories Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day gain of 0.14%, the pharmaceutical giant’s technical parameters reveal a complex picture of weakening momentum and cautious investor sentiment as it navigates a challenging market environment.